Flagship Biotech International Pvt. Ltd. is a fully integrated specialty Pharmaceutical Formulations Company engaged in Manufacturing, Exporting & Supplying supreme grade Zuclopenthixol Decanoate Injection to worldwide. These injections are formulated in our state-of-the art unit using high quality compounds. Our success in the industry is been built on the strong pillars of persistent efforts, business insight, experienced workforce, innovation, quality, and dedicated customer service.
Zuclopenthixol Decanoate Injection is used for the initial treatment of short-term psychoses like mania or increased severity of existing psychoses.
Zuclopenthixol Decanoate Injection is also used to treat schizophrenia (psychiatric disorder with symptoms of emotional instability, detachment from reality, often with delusions and hallucinations, and withdrawal into the self).
Zuclopenthixol Decanoate Injection belongs to a group of medicines called neuroleptics. Zuclopenthixol Decanoate Injection works by blocking certain chemicals present in the brain and thus helps to reduce psychoses.